Milestone Pharmaceuticals in its public offering of common shares and pre-funded warrants

Milestone Pharmaceuticals Inc. in its $45 million public offering

On October 27, 2020, Milestone Pharmaceuticals Inc. completed its $45 million public offering. The offering was made through a syndicate of underwriters with Jefferies and Piper Sandler as joint book running managers for the offering and Oppenheimer & Co. as lead manager. Milestone...

Lead Office: Montreal Date Closed: October 27, 2020 Value: $45 million

Milestone Pharmaceuticals Inc. in its US$82.5 million initial public offering

On May 13, 2019, Milestone Pharmaceuticals Inc. announced the closing of its previously announced initial public offering of 5,500,000 of its common shares at a public offering price of $15.00 per share. Milestone Pharmaceuticals Inc., a Montreal-based company, is a Phase 3 clinical-stage...

Lead Office: Montreal Date Closed: 13 May 2019 Value: US$82.5 million